13,616 reports of this reaction
2.6% of all METFORMIN ER 750 MG reports
#6 most reported adverse reaction
ACUTE KIDNEY INJURY is the #6 most commonly reported adverse reaction for METFORMIN ER 750 MG, manufactured by Granules Pharmaceuticals Inc.. There are 13,616 FDA adverse event reports linking METFORMIN ER 750 MG to ACUTE KIDNEY INJURY. This represents approximately 2.6% of all 532,492 adverse event reports for this drug.
Patients taking METFORMIN ER 750 MG who experience acute kidney injury should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ACUTE KIDNEY INJURY is a less commonly reported adverse event for METFORMIN ER 750 MG, but still significant enough to appear in the safety profile.
In addition to acute kidney injury, the following adverse reactions have been reported for METFORMIN ER 750 MG:
The following drugs have also been linked to acute kidney injury in FDA adverse event reports:
ACUTE KIDNEY INJURY has been reported as an adverse event in 13,616 FDA reports for METFORMIN ER 750 MG. This does not prove causation, but indicates an association observed in post-market surveillance data.
ACUTE KIDNEY INJURY accounts for approximately 2.6% of all adverse event reports for METFORMIN ER 750 MG, making it a notable side effect.
If you experience acute kidney injury while taking METFORMIN ER 750 MG, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.